These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10501231)

  • 1. Enhancement of DNA vaccine potency using conventional aluminum adjuvants.
    Ulmer JB; DeWitt CM; Chastain M; Friedman A; Donnelly JJ; McClements WL; Caulfield MJ; Bohannon KE; Volkin DB; Evans RK
    Vaccine; 1999 Aug; 18(1-2):18-28. PubMed ID: 10501231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate.
    Wang S; Liu X; Fisher K; Smith JG; Chen F; Tobery TW; Ulmer JB; Evans RK; Caulfield MJ
    Vaccine; 2000 Jan; 18(13):1227-35. PubMed ID: 10649624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between immunogenicity and adsorption of a recombinant Streptococcus pneumoniae vaccine antigen by an aluminum adjuvant.
    Levesque PM; Foster K; de Alwis U
    Hum Vaccin; 2006; 2(2):74-7. PubMed ID: 17012880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants.
    Sokolovska A; Hem SL; HogenEsch H
    Vaccine; 2007 Jun; 25(23):4575-85. PubMed ID: 17485153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
    Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
    Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant synergy in the response to hepatitis B vaccines.
    Wang S; Liu X; Caulfield MJ
    Vaccine; 2003 Oct; 21(27-30):4297-306. PubMed ID: 14505912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.
    Berthold I; Pombo ML; Wagner L; Arciniega JL
    Vaccine; 2005 Mar; 23(16):1993-9. PubMed ID: 15734073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid DNA vaccines: tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA.
    Manam S; Ledwith BJ; Barnum AB; Troilo PJ; Pauley CJ; Harper LB; Griffiths TG; Niu Z; Denisova L; Follmer TT; Pacchione SJ; Wang Z; Beare CM; Bagdon WJ; Nichols WW
    Intervirology; 2000; 43(4-6):273-81. PubMed ID: 11251382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.
    Romero Méndez IZ; Shi Y; HogenEsch H; Hem SL
    Vaccine; 2007 Jan; 25(5):825-33. PubMed ID: 17014935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminium phosphate potentiates the efficacy of DNA vaccines against Leishmania mexicana.
    Rosado-Vallado M; Mut-Martin M; García-Miss Mdel R; Dumonteil E
    Vaccine; 2005 Nov; 23(46-47):5372-9. PubMed ID: 16054271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced potency of individual and bivalent DNA replicon vaccines or conventional DNA vaccines by formulation with aluminum phosphate.
    Yu YZ; Wang WB; Li N; Wang S; Yu WY; Sun ZW
    Biologicals; 2010 Nov; 38(6):658-63. PubMed ID: 20805035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response.
    Kwissa M; Lindblad EB; Schirmbeck R; Reimann J
    J Mol Med (Berl); 2003 Aug; 81(8):502-10. PubMed ID: 12879151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
    Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
    Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enhancement of a hepatitis B DNA vaccine potency using aluminum phosphate in mice].
    Liang ZW; Ren H; Lang YH; Li YG
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):79-81. PubMed ID: 14980105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.
    Richards RL; Alving CR; Wassef NM
    J Pharm Sci; 1996 Dec; 85(12):1286-9. PubMed ID: 8961140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparative Study of the Effects of Al(OH)
    Heidary R; Nikbakht Brujeni G; Lotfi M; Hajizadeh A; Yousefi AR
    Arch Razi Inst; 2023 Dec; 78(6):1779-1786. PubMed ID: 38828184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response.
    Noe SM; Green MA; HogenEsch H; Hem SL
    Vaccine; 2010 Apr; 28(20):3588-94. PubMed ID: 20211692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the adjuvanticity of aluminum salts and their combination in hepatitis B recombinant protein vaccine in assessed mice.
    Mahboubi A; Fazeli MR; Dinarvand R; Samadi N; Sharifzadeh M; Ilka H; Azadi S; Soleimanian R; Kalkouei H; Hajikhanmirzaei R; Valadkhani M
    Iran J Immunol; 2008 Sep; 5(3):163-70. PubMed ID: 18791283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of alternative aluminum adjuvants on the absorption and immunogenicity of HPV16 L1 VLPs in mice.
    Caulfield MJ; Shi L; Wang S; Wang B; Tobery TW; Mach H; Ahl PL; Cannon JL; Cook JC; Heinrichs JH; Sitrin RD
    Hum Vaccin; 2007; 3(4):139-45. PubMed ID: 17581283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased immunogenicity of recombinant Ad35-based malaria vaccine through formulation with aluminium phosphate adjuvant.
    Ophorst OJ; Radosević K; Klap JM; Sijtsma J; Gillissen G; Mintardjo R; van Ooij MJ; Holterman L; Companjen A; Goudsmit J; Havenga MJ
    Vaccine; 2007 Aug; 25(35):6501-10. PubMed ID: 17646036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.